Video

TransIT-VirusGEN Transfection For AAV And Lentivirus Production

Source: Mirus Bio

Mirus Bio has been developing transfection reagents and proprietary technologies for nucleic acid delivery applications for over 25 years. Together with Gamma Biosciences, Mirus Bio is developing technologies that help product developers within the cell and gene therapy space optimize their processes. The goal of these developments is to provide GMP compliant product and industry expertise to clients. As the industry approaches a new era of addressing and conquering life-altering diseases, Mirus Bio is working to expand their expertise and leadership in transfection to be integral in the future of advanced therapies.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Mirus Bio